MODERN APPROACHES TO THE DIAGNOSIS AND TREATMENT OF ENDOCERVICITIS AND COLPITIS IN PREGNANT WOMEN
##plugins.themes.bootstrap3.article.main##
Abstrak:
Endocervicitis and colpitis are common inflammatory conditions of the lower female genital tract that require particular clinical attention during pregnancy. Physiological immunological adaptations, hormonal fluctuations, and alterations in the vaginal microenvironment during gestation contribute to increased susceptibility to cervicovaginal infections. When inadequately diagnosed or managed, these conditions may be associated with unfavorable obstetric outcomes, including preterm delivery, premature rupture of membranes, intrauterine infection, and postpartum inflammatory complications. Recent advances in obstetric care have emphasized the importance of early diagnosis and individualized treatment strategies to minimize maternal and fetal risks. Modern diagnostic approaches incorporate a combination of clinical assessment, laboratory-based microbiological testing, and molecular diagnostic techniques, which enhance pathogen detection and improve diagnostic accuracy. Therapeutic strategies have evolved toward safer, gestational-age–appropriate antimicrobial regimens, supported by growing evidence on fetal safety and treatment efficacy. This article aims to present a comprehensive overview of contemporary approaches to the diagnosis and treatment of endocervicitis and colpitis in pregnant women, integrating current clinical evidence and international recommendations to support optimal clinical decision-making.
##plugins.themes.bootstrap3.article.details##
##submission.howToCite##:
##submission.citations##:
Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1–187.
World Health Organization. WHO guidelines for the management of sexually transmitted infections. Geneva: WHO; 2021.
Sobel JD, Mitchell C. Vaginal microbiome and its role in recurrent vaginitis. Clin Obstet Gynecol. 2021;64(1):21–32.
Hillier SL, Brotman RM. Making the case for vaginal microbiota as a key determinant of women’s reproductive health. BJOG. 2023;130(2):142–149.
Romero R, Gomez-Lopez N, Winters AD, et al. The immunology of pregnancy and infection. Nat Rev Immunol. 2020;20(8):483–500.
Kroon SJ, Ravel J, Huston WM. Cervicovaginal microbiota, women’s health, and reproductive outcomes. Fertil Steril. 2021;116(4):927–935.
Gaydos CA, Van Der Pol B. Advances in molecular diagnostics for sexually transmitted infections. Infect Dis Clin North Am. 2020;34(2):273–290.
Unemo M, Seifert HS, Hook EW. Gonorrhoea. Nat Rev Dis Primers. 2019;5:79. (Used for diagnostic context)
American College of Obstetricians and Gynecologists. Vaginitis in pregnancy: Clinical management guidelines. Obstet Gynecol. 2022;140(6):e231–e246.
NICE Guideline. Preterm labour and birth. London: National Institute for Health and Care Excellence; 2022.
Hanson L, Vangay P, McManus D. Probiotics in pregnancy and vaginal health. Front Cell Infect Microbiol. 2021;11:689983.
Falagas ME, Betsi GI, Athanasiou S. Probiotics for prevention of recurrent vaginitis. Clin Microbiol Infect. 2020;26(10):1293–1301.
